pirenperone has been researched along with Disease Models, Animal in 4 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment of pirenperone increased the expression level of Fmr1 gene." | 5.72 | Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice. ( Ahn, T; Gonzales, EL; Jeon, SJ; Kim, Y; Remonde, CG; Shin, CY; Shin, D, 2022) |
| "Treatment of pirenperone increased the expression level of Fmr1 gene." | 1.72 | Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice. ( Ahn, T; Gonzales, EL; Jeon, SJ; Kim, Y; Remonde, CG; Shin, CY; Shin, D, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Kim, Y | 2 |
| Jeon, SJ | 2 |
| Gonzales, EL | 2 |
| Shin, D | 2 |
| Remonde, CG | 2 |
| Ahn, T | 2 |
| Shin, CY | 2 |
| Colpaert, FC | 1 |
| Meert, TF | 1 |
| Niemegeers, CJ | 1 |
| Janssen, PA | 1 |
4 other studies available for pirenperone and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Mice; Mic | 2022 |
Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Mice; Mic | 2022 |
Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Mice; Mic | 2022 |
Pirenperone relieves the symptoms of fragile X syndrome in Fmr1 knockout mice.
Topics: Animals; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Mice; Mic | 2022 |
Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Diazepam; Disease Mode | 1985 |